Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention

References

• Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med.331, 489–495 (1994).
   PubMed Web of Science ®Google Scholar
• Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med.331, 496–501 (1994).
   PubMed Web of Science ®Google Scholar
• Peterson ED, Cowper PA, DeLong ER, Zidar JP, Stack RS, Mark DB. Acute and long-term cost implications of coronary stenting. J. Am. Coll. Cardiol.33, 1610–1618 (1999).
   Google Scholar
• Al Suwaidi J, Berger PB, Holmes DR Jr. Coronary artery stents. JAMA284, 1828–1836 (2000).
   Web of Science ®Google Scholar
• Abizaid A, Kornowski R, Mintz GS et al. The influnce of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J. Am. Coll. Cardiol.32, 584–589 (1998).
   PubMed Web of Science ®Google Scholar
• Kastrati A, Hall D, Schömig A. Long-term outcome after coronary stenting. Curr. Control Trials Cardiovasc. Med.1, 48–54 (2000).
   PubMedGoogle Scholar
• Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med.350, 221–231 (2004).
   PubMed Web of Science ®Google Scholar
• Moses JW, Leon MB, Popma JJ et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med.349, 1315–1323 (2003).
   PubMed Web of Science ®Google Scholar
• Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first generation drug-eluting stents: a cause for concern. Circulation115, 1440–1455 (2007).
   PubMed Web of Science ®Google Scholar
• Lagerqvist B, James SK, Stenestrand U et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med.356, 1009–1019 (2007).
   PubMed Web of Science ®Google Scholar
• Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur. Heart J.27, 2784–2814 (2006).
   PubMed Web of Science ®Google Scholar
• Windecker S, Simon R, Lins M et al. Randomized comparison of a titanium-nitride oxide-coated stent with a stainless steel stent for coronary revascularization. The TINOX trial. Circulation111, 2617–2622 (2005).
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Ylitalo A, Airaksinen KE. Real world experience with the TITAN stent: a 9-month follow-up report from the Titan PORI registry. EuroInterv.2, 187–191 (2006).
   PubMedGoogle Scholar
• Mosseri M, Miller H, Tamari I et al. The titanium-NO stent: results of a multicenter registry. EuroInterv.2, 192–196 (2006).
   PubMedGoogle Scholar
• Mosseri M, Tamari I, Plich M et al. Short and long term outcome of the Titanium-NO stent registry. Cardiovasc. Revasc. Med.6(1), 2–6 (2005).
   PubMedGoogle Scholar
• Giraud-Sauveur Y. Titan 2 bio-active stent (BAS) with titanium-NO. EuroInterv.3, 526–528 (2007).
   Google Scholar
• Karjalainen PP, Ylitalo A, Airaksinen JK. Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J. Invasive Cardiol.18, 462–468 (2006).
   PubMedGoogle Scholar
• Karjalainen PP, Annala AP, Ylitalo A, Vahlberg T, Airaksinen KE. Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int. J. Cardiol. DOI: 10.1016/j.ijcard.2009.03.120 (2009) (In press).
   Google Scholar
• Karjalainen PP, Ylitalo A, Niemelä M et al. Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. EuroInterv4(2), 234–241 (2008).
   PubMedGoogle Scholar
• Karjalainen PP, Ylitalo A, Niemela M et al. Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann. Med.21, 1–9 (2009).
   Google Scholar
• Steinemann SG. Metal implants and surface reactions. Injury27, SC16–22 (1996).
   PubMedGoogle Scholar
• Zhang F, Chen Y, Zheng Z et al. Synthesis and blood compatibility of rutile-type titanium oxide coated LTI-carbon. Sci. China C. Life Sci.41(4), 400–405 (1998).
   PubMedGoogle Scholar
• Zhang F, Zheng Z, Chen Y, Liu X, Chen A, Jiang Z. In vivo investigation of blood compatibility of titanium oxide films. J. Biomed. Mater. Res.42(1), 128–133 (1998).
   PubMed Web of Science ®Google Scholar
• Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH. Comparison of endothelial cells grown on different stent materials. J. Biomed. Mater. Res. A76, 835–841 (2006).
   PubMed Web of Science ®Google Scholar
• Tsyganov I, Maitz MF, Wieser E, Richter E, Reuther H. Correlation between blood compatibility and physical surface properties of titanium-based coatings. Surface and Coatings Technology200, 1041–1044 (2005).
   Web of Science ®Google Scholar
• Tsyganov IA, Maitz MF, Richter E, Reuther H, Mashina AI, Rustichelli F. Hemocompatibility of titanium-based coatings prepared by metal plasma immersion ion implantation and deposition. Nucl. Instrum. Methods Phys. Res. B.257, 122–127 (2007).
   Google Scholar
• Windecker S, Billinger M, Hess OM. Stent coating with titanium-nitride-oxide for prevention of restenosis. EuroInterv.2(2), 146–148 (2006).
   PubMedGoogle Scholar
• Windecker S, Mayer I, De Pasquale G et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation104, 928–933 (2001).
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kopia G, Hayashi S et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation104, 1188–1193 (2001).
   PubMed Web of Science ®Google Scholar
• Sansa M, Cernigliaro C, Rosso R et al. Comparison randomisée de l’utilisation de stents couverts au titane-nitride-oxyde dans l’ischémie aiguë: effets sur la thrombose précoce et tardive, et sur la resténose angiographique. Archives maladies du coeur et des vaisseaux98(12) (2005).
   Google Scholar
• Sant’Anna FM, Batista LA, Brito MB et al. Randomized comparison of percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus stainless steel stents in patients with coronary artery disease: RIO trial. Rev. Bras. Cardiol. Invas.17(1), 69–75 (2009).
   Google Scholar
• Lauterburg A, Lötscher S, Raeber L et al. Clinical outcome following PCI using titanium nitride oxide coated stents in complex patients, compared with Cypher- and Taxus-stents in a clinical registry. The BERN Registry. Presented at: TransCatherter Therapeutics. San Francisco, CA, USA, 21–25 September (2009).
   Google Scholar
• Valdes M, Fernandez J, Bethencourt A et al. The TIBET Registry. Clinical and angiographic events in diabetes patients treated with the TITAN stent. Am. J. Cardiol.94(Suppl. 6A), 47E (2004).
   Google Scholar
• Valdesuso R, Karjalainen P, Garcia J et al. The EXTREME Registry: Titanium-nitride-oxide coated stents in small coronary arteries. Catheter. Cardiovasc. Interv.76(2), 281–287 (2010).
   PubMed Web of Science ®Google Scholar
• Calvo I, Galache JG, Diarte JA, Sanchez-Rubio J. Clinical effectiveness of Titanium-NO stent in acute STEMI. Presented at: European Society of Cardiology Congress. Vienna, Austria, 1–5 September (2007).
   Google Scholar
• Karjalainen PP, Biancari F, Ylitalo A et al. Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting. J. Invas. Cardiol.22(7), 322–326 (2010).
   PubMed Web of Science ®Google Scholar
• Kaiser C, Brunner-La Rocca HP et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet366(9489), 921–929 (2005).
   PubMed Web of Science ®Google Scholar